The role of JAM-A in inflammatory bowel disease: Unrevealing the ties that bind

Annals of the New York Academy of Sciences

Volumn 1165, Issue , 2009, Pages 308-313

  Vetrano, Stefania ^a   Danese, Silvio ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Inflammatory bowel disease (IBD); Junctional adhesion molecule A (JAM A); Tight junctions

Indexed keywords

CELL ADHESION MOLECULE; JUNCTIONAL ADHESION MOLECULE A;

ARTICLE; ENDOTHELIUM CELL; ENTERITIS; EPITHELIUM CELL; INTESTINE FUNCTION; LEUKOCYTE; MEMBRANE PERMEABILITY; PATHOGENESIS; PROTEIN EXPRESSION; TIGHT JUNCTION;

EID: 67249112673     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04045.x     Document Type: Article

References (42)

1. Stefanelli, T. et al. 2008. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets. Curr. Drug Targets 9: 413-418.
2. Wyatt, J. et al. 1993. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341: 1437-1439.
3. Schneeberger, E.E. & R.D. Lynch. 2004. The tight junction: a multifunctional complex. Am. J. Physiol. Cell Physiol. 286: C1213-C1228.
4. Gitter, A.H. et al. 2001. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 121: 1320-1328.
5. Katz, K.D. et al. 1989. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 97: 927-931.
6. Schmitz, H. et al. 1999. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116: 301-309.
7. Bruewer, M. et al. 2005. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. Faseb J. 19: 923- 933.
8. Utech, M. et al. 2005. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol. Biol. Cell 16: 5040-5052.
9. Karayiannakis, A.J. et al. 1998. Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease. J. Pathol. 185: 413-418.
10. Dogan, A., Z.D. Wang & J. Spencer. 1995. E-cadherin expression in intestinal epithelium. J. Clin. Pathol. 48: 143-146.
11. Gibson, P.R. et al. 1988. Ulcerative colitis-a disease characterised by the abnormal colonic epithelial cell? Gut 29: 516-521.
12. Gibson, P. et al. 1995. Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer. Gut 36: 857-863.
13. Gassler, N. et al. 2001. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G216-G228.
14. Marin, M.L. et al. 1983. Ultrastructural pathology of Crohn's disease: correlated transmission electron microscopy, scanning electron microscopy, and freeze fracture studies. Am. J. Gastroenterol. 78: 355-364.
15. Kucharzik, T. et al. 2001. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am. J. Pathol. 159: 2001-2009.
16. Prasad, S. et al. 2005. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab. Invest. 85: 1139-1162.
17. Bazzoni, G. 2003. The JAM family of junctional adhesion molecules. Curr. Opin. Cell Biol. 15: 525-530.
18. Martin-Padura, I. et al. 1998. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142: 117-127.
19. Palmeri, D. et al. 2000. Vascular endothelial junctionassociated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J. Biol. Chem. 275: 19139-19145.
20. Cunningham, S.A. et al. 2000. A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. J. Biol. Chem. 275: 34750-34756.
21. Hirabayashi, S. et al. 2003. JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1. Mol. Cell Biol. 23: 4267-4282.
22. Aurrand-Lions, M. et al. 2001. JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J. Biol. Chem. 276: 2733-2741.
23. Liu, Y. et al. 2000. Human junction adhesion molecule regulates tight junction resealing in epithelia. J. Cell Sci. 113(Pt 13): 2363-2374.
24. Williams, L.A. et al. 1999. Identification and characterisation of human junctional adhesion molecule (JAM). Mol. Immunol. 36: 1175-1188.
25. Shao, M. et al. 2008. JAM-A is present in mammalian spermatozoa where it is essential for normal motility. Dev. Biol. 313: 246-255.
26. Guglielmi, K.M. et al. 2007. Reovirus binding determinants in junctional adhesion molecule-A. J. Biol. Chem. 282: 17930-17940.
27. Weber, C., L. Fraemohs & E. Dejana. 2007. The role of junctional adhesion molecules in vascular inflammation. Nat. Rev. Immunol. 7: 467-477.
28. Bazzoni, G. et al. 2000. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J. Biol. Chem. 275: 20520-20526.
29. Ebnet, K. et al. 2000. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J. Biol. Chem. 275: 27979-88.
30. Ebnet, K. et al. 2001. The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). Embo J. 20: 3738-3748.
31. Konopka, G. et al. 2007. Junctional adhesion molecule-A is critical for the formation of pseudocanaliculi and modulates E-cadherin expression in hepatic cells. J. Biol. Chem. 282: 28137-28148.
32. Mandell, K.J. et al. 2007. Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function. Invest. Ophthalmol. Vis. Sci. 48: 3928-3936.
33. Stefania Vetrano, M.R., M.R. Cera, C. Correale, et al. 2008. Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology in press:
34. Schulzke, J.D. et al. 2005. Epithelial transport and barrier function in occludin-deficient mice. Biochim. Biophys. Acta 1669: 34-42.
35. Laukoetter, M.G. et al. 2007. JAM-A regulates permeability and inflammation in the intestine in vivo. J. Exp. Med. 204: 3067-3076.
36. Colegio, O.R. et al. 2002. Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am. J. Physiol. Cell Physiol. 283: C142-C147.
37. Van Itallie, C.M. et al. 2006. Two splice variants of claudin-10 in the kidney create paracellular pores with different ion selectivities. Am. J. Physiol. Renal Physiol. 291: F1288-F1299.
38. Heller, F. et al. 2005. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129: 550-564.
39. Ma, T.Y. et al. 2004. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G367-G376.
40. Al-Sadi, R.M. & T.Y. Ma. 2007. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 178: 4641-4649.
41. Mandell, K.J. et al. 2005. Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity. J. Biol. Chem. 280: 11665-11674.
42. Nenci, A. et al. 2007. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446: 557-561.